New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis

New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis

The process of neurodegeneration in multiple sclerosis (MS) remains an urgent problem of modern neurology; from the point of view of its therapy, it is especially important to identify this condition during the transition to secondary progression. This paper reflects the opinion of the Council of Le...

Full description

Bibliographic Details
Main Authors: D. S. Kasatkin, N. V. Khachanova, V. M. Alifirova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, M. V. Davydovskaya, E. P. Evdoshenko, S. A. Sivertseva
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2021-02-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
multiple sclerosis
secondary progressive multiple sclerosis
neurodegeneration
council of experts
siponimod
Online Access:https://nnp.ima-press.net/nnp/article/view/1513

Internet

https://nnp.ima-press.net/nnp/article/view/1513

Similar Items